7 days Ocugen (OCGN) Reports Q3 Loss, Misses Revenue EstimatesZacks

Ocugen (OCGN) delivered earnings and revenue surprises of 0% and 5.33%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

20 hours China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drugInvesting.com X

1 day Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?Zacks X

2 days Regeneron: The Biotech Stock To Buy NowSeeking Alpha X

2 days Biotech: 3 Reasons The Recent Selloff Is A Buying Opportunity For XBI (Upgrade)Seeking Alpha X

2 days Best Biotech Stocks Right NowBenzinga X

2 days The Zacks Analyst Blog Highlights SPDR S&P Biotech ETF, SPDR S&P Semiconductor ETF, First Trust Indxx Aerospace & Defense ETF, First Trust NASDAQ-100-Technology Sector Index Fund and iShares U.S. Digital Infrastructure and Real Estate ETFZacks X

3 days Here are 4 biotech stocks that could get a boost from Trump’s new regulatory climateMarketWatch X

3 days Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on ItZacks X

3 days Biotech Stocks To Watch And Pharma Industry NewsInvestor's Business Daily X

4 days Is It Too Late to Buy Viking Therapeutics Stock?The Motley Fool X

5 days 2 Reasons to Buy Amgen Stock, and 1 Reason to Be CautiousThe Motley Fool X

5 days 2 Top Biotech Stocks to Buy Now and Hold For 5 Years or MoreThe Motley Fool X

5 days RBC’s top 10 questions and answers on biotech stocksInvesting.com X

6 days Merck Inks $3.3B Licensing Deal With Chinese Biotech for Cancer TherapyZacks X

6 days The Cream Of The Crop: 5 Biotechs That Outrank Most StocksInvestor's Business Daily X

6 days Trump Taps RFK for HHS: Time to Avoid Biotech?Zacks X

6 days Oncolytics Biotech Inc. (NASDAQ:ONCY) Q3 2024 Earnings Call TranscriptInsider Monkey X

6 days Where Will CRISPR Therapeutics Be in 3 Years?The Motley Fool X

6 days Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?The Motley Fool X

6 days The Stocks Our Experts Are Trading NowInvestorPlace X

7 days Sagimet: More Than Just A MASH Drug Development BiotechSeeking Alpha X

7 days Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study DataZacks X

7 days BNTX to Boost Oncology Pipeline With Biotheus Acquisition, Stock UpZacks X

7 days Citi initiates coverage on 5 new biotech stocksInvesting.com X

1 week Oncolytics Biotech Inc. (ONCY) Q3 2024 Earnings Call TranscriptSeeking Alpha X

1 week Meet the Biotech Stock That Has Generated Nvidia-Like Returns in Less Than a MonthThe Motley Fool X

1 week This biotech’s stock could double if its treatment for major depressive disorder succeeds, says MizuhoMarketWatch X

1 week Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation OpportunityThe Motley Fool X

1 week FibroGen (FGEN) Reports Q3 Loss, Tops Revenue EstimatesZacks X

1 week Legend Biotech Corporation (LEGN) Q3 2024 Earnings Call TranscriptSeeking Alpha X

1 week Top Biotech Neurogene Crashes 44%, Wiping Out Its Sprint On A $200 Million DealInvestor's Business Daily X

1 week Bristol Myers Stock Trading Near 52-Week High: Time to Buy or Sell?Zacks X

1 week Tevogen Bio Partners with Microsoft Corporation (MSFT) to Leverage Advanced AI Tools for Biotech Research in HealthcareInsider Monkey X

2 weeks 1 Growing Biotech Stock to Buy Today With $1,000 and Hold for 5 Years or MoreThe Motley Fool X

2 weeks 2 Biotech Stocks You Can Buy Hand Over Fist This MonthThe Motley Fool X

2 weeks 5 Small Drug Stocks to Buy as Trump Gets Re-ElectedZacks X

2 weeks Biotech startup works on new regenerative drugsYouTube X

2 weeks Why Guardant Health Stock Blasted 13% Higher on ThursdayThe Motley Fool X

2 weeks Moderna’s stock pops after biotech ekes out a surprise profit, and revenue beats by a wide marginMarketWatch X

2 weeks Why TransMedics Stock Plunged in OctoberThe Motley Fool X

2 weeks Gilead’s third-quarter earnings beat by a wide margin, and biotech raises guidanceMarketWatch X

2 weeks Biotech Stocks Edge Higher. Could Trump 2.0 Mean More Innovation, Dealmaking?Investor's Business Daily X

2 weeks Intellia Therapeutics Just Notched Another Win. So Why Did Its Stock Fall 18% in 1 Day?The Motley Fool X

2 weeks What’s in Store for These 5 Drug & Biotech Stocks in Q3 Earnings?Zacks X

2 weeks Krystal Q3 Earnings and Sales Top Estimates, Vyjuvek Gains TractionZacks X

2 weeks Why Summit Therapeutics Stock Was a Winner TodayThe Motley Fool X

2 weeks Why Viking Therapeutics Stock Plummeted After Soaring TodayThe Motley Fool X

2 weeks Krystal Biotech, Inc. (KRYS) Q3 2024 Earnings Call TranscriptSeeking Alpha X

2 weeks Gilead Science to Report Q3 Earnings: What’s in the Cards?Zacks X

2 weeks This Beaten-Down Stock Could Soar by 354%, According to Wall StreetThe Motley Fool X